sorafenib has been researched along with telaprevir in 1 studies
| Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (telaprevir) | Trials (telaprevir) | Recent Studies (post-2010) (telaprevir) |
|---|---|---|---|---|---|
| 6,520 | 730 | 5,251 | 985 | 136 | 835 |
| Protein | Taxonomy | sorafenib (IC50) | telaprevir (IC50) |
|---|---|---|---|
| NS3 protease | 0.9757 | ||
| Cathepsin L2 | Homo sapiens (human) | 1.35 | |
| Prothrombin | Homo sapiens (human) | 1 | |
| Plasminogen | Homo sapiens (human) | 8.7 | |
| Procathepsin L | Homo sapiens (human) | 3.5 | |
| Cathepsin B | Homo sapiens (human) | 2.3033 | |
| Neutrophil elastase | Homo sapiens (human) | 5.56 | |
| Chymase | Homo sapiens (human) | 0.026 | |
| Cathepsin S | Homo sapiens (human) | 0.3 | |
| Cathepsin K | Homo sapiens (human) | 0.63 | |
| Chymotrypsin-like elastase family member 1 | Homo sapiens (human) | 0.03 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pár, A; Pár, G | 1 |
1 other study(ies) available for sorafenib and telaprevir
| Article | Year |
|---|---|
[The 43rd Annual Meeting of the European Association for the Study of the Liver (EASL), Milan, Italy, April 23-27, 2008].
Topics: Antineoplastic Agents; Antiviral Agents; Benzenesulfonates; Carcinoma, Hepatocellular; Clinical Trials as Topic; Delayed-Action Preparations; Europe; Hepatitis B; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Liver Diseases; Liver Neoplasms; Niacinamide; Oligopeptides; Patient Compliance; Phenylurea Compounds; Polyethylene Glycols; Proline; Pyridines; Recombinant Proteins; Ribavirin; Societies, Medical; Sorafenib | 2008 |